AstraZeneca's Lynparza meets main goal of late-stage cancer study

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 66%

Health Health Headlines News

British drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck & Co met the primary goal in a ...

AstraZeneca's Lynparza meets main goal of late-stage cancer study close breaking news Health AstraZeneca's Lynparza meets main goal of late-stage cancer study British drugmaker AstraZeneca Plc said on Tuesday its cancer drug being jointly developed with U.S.-based Merck & Co met the primary goal in a late-stage study for pancreatic cancer.

The logo of AstraZeneca is seen on medication packages in a pharmacy in London April 28, 2014. Stefan Wermuth 26 Feb 2019 03:36PM

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck's Keytruda fails late-stage study in liver cancer patientsMerck & Co Inc said on Tuesday its cancer drug Keytruda failed the main goals of a late-stage trial and did not extend life of patients with a ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Intercept's drug for patients with liver fibrosis due to NASH meets main goalREUTERS: Intercept Pharmaceuticals Inc said on Tuesday its treatment testing patients with liver fibrosis due to nonalcoholic steatohepatitis ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Vaccine could virtually eliminate cervical cancer: StudyPARIS (AFP) - The rapid scale-up of the human papillomavirus (HPV) vaccine could virtually eliminate cervical cancer in a handful of rich countries within three decades, and in most other nations by century's end, researchers said on Wednesday (Feb 20).. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Vaccine could virtually eliminate cervical cancer: studyThe rapid scale-up of the human papillomavirus (HPV) vaccine could virtually eliminate cervical cancer in a handful of rich countries within three decades, and in most other nations by century's end, researchers said Wednesday. Without screening and HPV vaccination, more than 44 million women will
Source: YahooSG - 🏆 3. / 71 Read more »